ESC 365 - Where PCSK9 inhibitors can make a difference

Open Access

Where PCSK9 inhibitors can make a difference

Session: LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Topic: Lipids

Speaker: Doctor C. Ballantyne (Houston, US)

Sponsored by Amgen Europe GmbH

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)

29 presentations

7 followers

3 more presentations in this session

Introduction - Treatment of ischemic heart disease patients in 2018

Speaker: Professor U. Landmesser (Berlin, DE)

What approach to CV risk management in 2018?

Speaker: Professor K. Ray (London, GB)

Panel discussion and wrap-up - LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Speaker: Professor U. Landmesser (Berlin, DE) Doctor C. Ballantyne (Houston, US) Professor K. Ray (London, GB)

Access the full session

LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Speakers: Doctor C. Ballantyne, Professor U. Landmesser, Professor K. Ray, Professor U. Landmesser, Doctor C. Ballantyne...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources